Opportunity Information: Apply for CDC RFA DD10 1012
Apply for CDC RFA DD10 1012
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Development and Dissemination of Evidence Based Clinical Care Guidelines for Muscular Dystrophies" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.184 Disabilities Prevention.
- This funding opportunity was created on Apr 15, 2010 and posted on Apr 15, 2010.
- Applicants must submit their applications by Jun 15, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,050,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $350,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) For profit organizations (other than small business) Small, minority, and women owned businesses Universities Colleges Research institutions Hospitals Community based organizations Faith based organizations Federally recognized or state recognized American Indian/Alaska Native tribal governments American Indian/Alaska native tribally designated organizations Alaska Native health corporations Urban Indian health organizations Tribal epidemiology centers State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) Political subdivisions of States (in consultation with States) A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a letter from the state or local government as documentation of the status is required.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This CDC discretionary grant opportunity (Funding Opportunity Number CDC RFA DD10-1012) focused on improving clinical care for people living with muscular dystrophies by creating and spreading evidence-based clinical care guidelines. The main goal was to produce practical, research-grounded guidance that clinicians can use in real-world decision making across the full continuum of care, including prevention considerations, diagnostic approaches, treatment and management strategies, and prognosis-related counseling. The program emphasized that the guidelines should be built on the best available scientific evidence, suggesting a structured evidence review process and careful translation of findings into recommendations that can be applied consistently in clinical settings.
A defining feature of the opportunity was its requirement to develop four separate sets of evidence-based guidelines, each tailored to a different muscular dystrophy type: myotonic dystrophy, limb-girdle muscular dystrophy, facioscapulohumeral muscular dystrophy, and congenital muscular dystrophy. By separating guideline development across these conditions, the announcement signaled that the CDC expected disease-specific recommendations rather than a single broad document, reflecting the meaningful differences among these disorders in genetics, typical clinical presentation, progression, complications, and multidisciplinary care needs. In practice, this kind of project would normally involve synthesizing clinical research, weighing strength and quality of evidence, addressing gaps where evidence is limited, and producing clear recommendations that can guide clinicians caring for both children and adults depending on the condition.
The funding mechanism was a grant, categorized under health, and the CDC expected to make one award. Total estimated funding was $1,050,000, with an award ceiling of $350,000 (and no stated award floor). There was no cost sharing or matching requirement, which typically means applicants were not required to contribute non-federal funds to be eligible or competitive. The opportunity was posted on April 15, 2010, with an application closing date of June 15, 2010, and it was later archived on July 15, 2010. The CFDA listing was 93.184, associated with disabilities prevention, which aligns with the public health intent of reducing the burden of disability through better prevention, early identification, and optimized care.
Eligibility was broad and included many organizational types that could reasonably lead a guideline-development and dissemination effort. Eligible applicants included nonprofits (with or without 501(c)(3) status, excluding institutions of higher education under that nonprofit category), for-profit organizations (other than small businesses), small/minority/women-owned businesses, and a wide range of health and research entities such as universities, colleges, research institutions, hospitals, community-based organizations, and faith-based organizations. Government entities were also eligible, including state and local governments and their bona fide agents, political subdivisions of states (with consultation), and a range of tribal governments and tribal or urban Indian health organizations, including tribal epidemiology centers and Alaska Native health corporations. For applicants applying as a bona fide agent of a state or local government, the CDC required documentation in the form of a letter from the relevant government confirming that status.
Overall, the opportunity was designed to fund a single organization (or a lead organization coordinating partners) to take on a substantial national-level clinical guideline effort in muscular dystrophy care. The expected outcome was not simply a literature review, but usable clinical care guidance that could be disseminated to influence practice, improve consistency of care, and support better health outcomes for individuals with these specific muscular dystrophies.
For administrative help accessing the full announcement, the listed contact was the CDC Procurement and Grants Office (770-488-2700; pgotim@cdc.gov).
Frequently Asked Questions (FAQs)
1) What is this CDC funding opportunity?
This is a CDC discretionary grant opportunity (Funding Opportunity Number CDC RFA DD10-1012) focused on improving clinical care for people living with muscular dystrophies by creating and spreading evidence-based clinical care guidelines.
2) What is the main purpose of the grant?
The main purpose is to produce practical, research-grounded clinical care guidance that clinicians can use in real-world decision making across the full continuum of care. The guidance is intended to support consistent, evidence-informed clinical practice and better health outcomes.
3) What kinds of clinical decisions should the guidelines address?
The guidelines are expected to cover the continuum of care, including prevention considerations, diagnostic approaches, treatment and management strategies, and prognosis-related counseling.
4) How many guideline products are required under this opportunity?
The opportunity requires four separate sets of evidence-based clinical care guidelines.
5) Which muscular dystrophy types must have their own guideline set?
The four required guideline sets must be tailored to:
- Myotonic dystrophy
- Limb-girdle muscular dystrophy
- Facioscapulohumeral muscular dystrophy
- Congenital muscular dystrophy
6) Does CDC expect one combined guideline document or disease-specific guidance?
The announcement signals that CDC expected disease-specific recommendations rather than a single broad document, reflecting meaningful differences among these disorders (such as genetics, typical clinical presentation, progression, complications, and multidisciplinary care needs).
7) What does "evidence-based" mean in the context of this program?
The program emphasized that the guidelines should be built on the best available scientific evidence. This implies a structured evidence review process and careful translation of findings into recommendations that can be applied consistently in clinical settings.
8) Is the expected outcome just a literature review?
No. The expected outcome is usable clinical care guidance that can be disseminated to influence practice and improve consistency of care, not simply a literature review.
9) How many awards did CDC expect to make?
CDC expected to make one award.
10) What is the total estimated funding for this opportunity?
The total estimated funding was $1,050,000.
11) What is the award ceiling?
The award ceiling was $350,000.
12) Is there an award floor?
No award floor was stated.
13) Is cost sharing or matching required?
No. There was no cost sharing or matching requirement, meaning applicants were not required to contribute non-federal funds to be eligible or competitive.
14) What type of funding mechanism is this?
The funding mechanism was a grant and it was categorized under health.
15) What is the CFDA number associated with this opportunity?
The CFDA listing was 93.184 (disabilities prevention).
16) When was the opportunity posted and when did it close?
It was posted on April 15, 2010, and the application closing date was June 15, 2010.
17) Is this opportunity still active?
No. The opportunity was later archived on July 15, 2010.
18) Who was eligible to apply?
Eligibility was broad and included multiple organizational types that could lead a guideline-development and dissemination effort, including:
- Nonprofits (with or without 501(c)(3) status, excluding institutions of higher education under that nonprofit category)
- For-profit organizations (other than small businesses)
- Small/minority/women-owned businesses
- Universities and colleges
- Research institutions
- Hospitals
- Community-based organizations
- Faith-based organizations
- State and local governments and their bona fide agents
- Political subdivisions of states (with consultation)
- Tribal governments and tribal or urban Indian health organizations (including tribal epidemiology centers and Alaska Native health corporations)
19) Are government entities eligible?
Yes. State and local governments and their bona fide agents, political subdivisions of states (with consultation), and tribal governments and tribal or urban Indian health organizations were included as eligible applicants.
20) What documentation is required if applying as a bona fide agent of a state or local government?
CDC required documentation in the form of a letter from the relevant government confirming the applicant's bona fide agent status.
21) What kind of organization was CDC intending to fund?
The opportunity was designed to fund a single organization (or a lead organization coordinating partners) to carry out a substantial national-level clinical guideline effort in muscular dystrophy care.
22) What is the intended public health rationale for this effort?
The CFDA association with disabilities prevention aligns with a public health intent to reduce the burden of disability through better prevention, early identification, and optimized care supported by evidence-based guidance.
23) Who should be contacted for administrative help accessing the full announcement?
For administrative help accessing the full announcement, the listed contact was the CDC Procurement and Grants Office at 770-488-2700 or pgotim@cdc.gov.
Browse more opportunities from the same category: Health
Next opportunity: Partnership for the National Trails System
Previous opportunity: Recovery Act PMIS #154950A National Park Service Vermont Youth Conservation Corps Trail Repair Along Appalachian Trail
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA DD10 1012
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA DD10 1012) also looked into and applied for these:
| Funding Opportunity |
|---|
| Addressing Syndemics Through Program Collaboration and Service Integration (PCSI) Apply for CDC RFA PS10 10175 Funding Number: CDC RFA PS10 10175 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Nurse Faculty Loan Program Apply for HRSA 10 142 Funding Number: HRSA 10 142 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Tribal Management Grant Program Apply for HHS 2011 IHS TMD 0001 Funding Number: HHS 2011 IHS TMD 0001 Agency: Indian Health Service Category: Health Funding Amount: $100,000 |
| Grants to Support the Historically Black Colleges and Universities Health Serv Apply for CMS 1I0 10 011 Funding Number: CMS 1I0 10 011 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $100,000 |
| Grants to Support the Hispanic Health Services Research Grant Program Apply for CMS 1H0 10 011 Funding Number: CMS 1H0 10 011 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $100,000 |
| AHRQ Small Research Grant Program (R03) Apply for PAR 10 168 Funding Number: PAR 10 168 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $100,000 |
| Institutional Training for a Dental and Craniofacial Research Workforce (T90/R90) Apply for PAR 10 170 Funding Number: PAR 10 170 Agency: National Institutes of Health Category: Health Funding Amount: $800,000 |
| Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Training for a Dental and Craniofacial Research Workforce (T32) Apply for PAR 10 171 Funding Number: PAR 10 171 Agency: National Institutes of Health Category: Health Funding Amount: $800,000 |
| Preparedness and Emergency Response Learning Centers (PERLC) Apply for CDC RFA TP10 1001 Funding Number: CDC RFA TP10 1001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $905,987 |
| Scholarships for Disadvantaged Students Apply for HRSA 10 111 Funding Number: HRSA 10 111 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| National Organizations For Chronic Disease Prevention and Health Promotion Apply for CDC RFA DP10 1008 Funding Number: CDC RFA DP10 1008 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Geriatric Academic Career Awards Apply for HRSA 10 228 Funding Number: HRSA 10 228 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Microbicide Innovation Program (MIP VI) (R21/R33) Apply for RFA AI 10 011 Funding Number: RFA AI 10 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| HIV/AIDS Policy Initiative Building State, County and Local Public Health Infrastructure Apply for CDC RFA PS10 1045 Funding Number: CDC RFA PS10 1045 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
| Integrated Health Social Marketing Program for Mozambique Apply for 656 10 XXX DRAFT RFA Funding Number: 656 10 XXX DRAFT RFA Agency: South Africa USAID Pretoria Category: Health Funding Amount: $35,000,000 |
| Grants to States for Loan Repayment Apply for HRSA 10 066 Funding Number: HRSA 10 066 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| CHIPRA Pediatric Healthcare Quality Measures Program Centers of Excellence (U18) Apply for RFA HS 11 001 Funding Number: RFA HS 11 001 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $2,000,000 |
| ARRA Training in Primary Care Medicine Residency Training in Primary Care Apply for HRSA 10 235 Funding Number: HRSA 10 235 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Injury Prevention Program Apply for HHS 2010 IHS IPP 0001 Funding Number: HHS 2010 IHS IPP 0001 Agency: Indian Health Service Category: Health Funding Amount: $80,000 |
| Jail based Integration of HIV/Sexually Transmitted Infection (STI)/Hepatitis Screening, Hepatitis B Vaccination, and Linkage to Care and Treatment Apply for CDC RFA PS10 10162 Funding Number: CDC RFA PS10 10162 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $980,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA DD10 1012", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.